4.7 Article

Caffeine suppresses TNF-α production via activation of the cyclic AMP/protein kinase A pathway

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 4, Issue 10-11, Pages 1409-1417

Publisher

ELSEVIER
DOI: 10.1016/j.intimp.2004.06.005

Keywords

caffeine; paraxanthine; immune; TNF-alpha; cAMP; protein kinase A

Ask authors/readers for more resources

This study investigated the effect of in vitro exposure to caffeine, and its major metabolite paraxanthine, at concentrations relevant to typical caffeine consumption in humans, on lipopolysaccharide (LPS)-stimulated cytokine production in human whole blood. In addition, a role for the cyclic AMP/protein kinase A (PKA) pathway in the immunomodulatory effect of caffeine was investigated. Diluted whole blood (taken following greater than or equal to 15 h abstinence from caffeine-containing food and beverages) was preincubated with caffeine or paraxanthine (10-100 muM) and stimulated with LPS (1 mug/ml) for 24 h. The proinflammatory cytokines tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-12, and the antiinflammatory cytokine IL-10 were measured in cell-free supernatants. Whilst caffeine and paraxanthine had little or no effect on IL-10, IL-1beta, or IL-12 production, TNF-alpha production was suppressed in all individuals studied. The effect was statistically significant at 100 muM and consistent across seven experiments performed. Although not statistically significant, a similar effect was observed with paraxanthine. Caffeine (100 muM) also increased intracellular cyclic AMP concentrations in LPS-stimulated monocytes isolated from whole blood. Moreover, the effect of caffeine on TNF-alpha production was abolished by pretreatment with the protein kinase A inhibitor Rp-8-Br-cAMPS (10(-4) and 10(-5) M). To conclude, this study demonstrates that concentrations of caffeine that are relevant to human consumption consistently suppress production of the proinflammatory cytokine TNF-a in human blood and that this effect is mediated by the cyclic AMP/protein kinase A pathway. (C) 2004 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available